Evolus reports Q4 preliminary revenue $34.7M (+68% YoY), guides 2022 revenue $143-150M

Evolus, Inc.

2021-FY EPS reported -$0.94 revenue$99,673,000

Q4 2021 preliminary net revenue $34.7M, up 68% YoY; full-year 2021 revenue $99.7M, up 76% YoY.
Cash position $146.3M at Dec 31, 2021; expects sufficient funding through cash flow breakeven.
2022 net revenue guidance $143-150M (43-50% growth); adjusted gross margin 58-61% full year, improving to 68-71% in Q4.
Plans to initiate Phase 2 'extra strength' Jeuveau trial in Q1 2022; European Nuceiva launch in Q3 2022.
Added 1,400+ new accounts in 2021; consumer loyalty program reached 270,000+.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.